API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
94
PharmaCompass offers a list of Dithranol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dithranol manufacturer or Dithranol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dithranol manufacturer or Dithranol supplier.
PharmaCompass also assists you with knowing the Dithranol API Price utilized in the formulation of products. Dithranol API Price is not always fixed or binding as the Dithranol Price is obtained through a variety of data sources. The Dithranol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Anthralin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anthralin, including repackagers and relabelers. The FDA regulates Anthralin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anthralin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anthralin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Anthralin supplier is an individual or a company that provides Anthralin active pharmaceutical ingredient (API) or Anthralin finished formulations upon request. The Anthralin suppliers may include Anthralin API manufacturers, exporters, distributors and traders.
click here to find a list of Anthralin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Anthralin CEP of the European Pharmacopoeia monograph is often referred to as a Anthralin Certificate of Suitability (COS). The purpose of a Anthralin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Anthralin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Anthralin to their clients by showing that a Anthralin CEP has been issued for it. The manufacturer submits a Anthralin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Anthralin CEP holder for the record. Additionally, the data presented in the Anthralin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Anthralin DMF.
A Anthralin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Anthralin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Anthralin suppliers with CEP (COS) on PharmaCompass.
A Anthralin written confirmation (Anthralin WC) is an official document issued by a regulatory agency to a Anthralin manufacturer, verifying that the manufacturing facility of a Anthralin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Anthralin APIs or Anthralin finished pharmaceutical products to another nation, regulatory agencies frequently require a Anthralin WC (written confirmation) as part of the regulatory process.
click here to find a list of Anthralin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anthralin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Anthralin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Anthralin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Anthralin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anthralin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Anthralin suppliers with NDC on PharmaCompass.
Anthralin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anthralin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anthralin GMP manufacturer or Anthralin GMP API supplier for your needs.
A Anthralin CoA (Certificate of Analysis) is a formal document that attests to Anthralin's compliance with Anthralin specifications and serves as a tool for batch-level quality control.
Anthralin CoA mostly includes findings from lab analyses of a specific batch. For each Anthralin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anthralin may be tested according to a variety of international standards, such as European Pharmacopoeia (Anthralin EP), Anthralin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anthralin USP).